Summary Australian based medical life science company Medlab Clinical has obtained an IND grant for NanaBis™ from the US FDA. With the FDA approval, Medlab can initiate its pivotal Phase 3 clinical trial at US sites. The Company has also...
A data-baked drug development firm, Emyria Limited (ASX:EMD) witnessed an impressive growth of 7.407% (A$0.145) at AEDT 2:57 PM in its shares post the release of its quarterly activities report for the quarter ended 31 December 2021. The Company l...
Summary Creso Pharma has received a repeat purchase order for its animal health products range, anibidiol® valued at A$247,826 from Virbac Switzerland. The new purchase order adds to the strong demand for its products across Europe, Latin A...
Summary Medibio Limited disclosed that its sleep staging software, MEBsleep, has obtained CE Mark approval. With the CE Mark, the health technology player can accelerate MEBsleep commercialisation activities in the EEC. The Company is investig...
Summary Factor Therapeutics has called off LONGMILE deal due to prolonged transaction process and changes in business circumstances. Net cash at the end of December 2020 quarter was reported at A$3.19 million. Factor Therapeutics’ share ...
Summary Chimeric Therapeutics commenced trading on the ASX today following the successful completion of its IPO. The drug development company raised almost A$35 million from Institutional as well as sophisticated investors. The Company would u...
Australian medical device company PolyNovo Limited (ASX:PNV) has recently released an update on its business performance. In its interim trading update, the company has reported an increase of 31% in sales for H1 FY21 when compared with t...
Summary The healthcare sector, considered a defensive one, witnessed an unprecedented rise in demand for healthcare products and services due to the COVID-19 pandemic. Starpharma to launch its COVID-19 spray VIRALEZE™ during the first qua...
Summary Innovative Australian company Nanollose has applied a patent for a superior tenacity lyocell fibre with Grasim Industries. The joint patent will provide the two companies additional IP as well as a premium fibre. Following the patent f...
Summary ASX-200 medical imaging player Pro Medicus enters in an agreement with Intermountain Healthcare to implement Visage 7 technology. The Intermountain deal represents the fifth major contract secured by Pro Medicus in the last six months. ...
Get a call to receive stock recommendation services from Kalkine Pty Ltd (www.kalkine.com.au)